Supplies - 274802-2019

13/06/2019    S112    - - Supplies - Contract award notice - Open procedure 

Finland-Helsinki: Vaccines

2019/S 112-274802

Contract award notice

Results of the procurement procedure


Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
National Institute for Health and Welfare
PL 30
NUTS code: FI1B

Internet address(es):

Main address:

I.2)Information about joint procurement
I.4)Type of the contracting authority
National or federal agency/office
I.5)Main activity

Section II: Object

II.1)Scope of the procurement

Contract for Procurement of Hepatitis A Vaccine (HAV)

Reference number: THL/433/8.00.02/2018
II.1.2)Main CPV code
II.1.3)Type of contract
II.1.4)Short description:

The Ministry of Social Affairs and Health (hereinafter ‘STM’) and National Institute for Health and Welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Hepatitis A Vaccine (HAV) belonging to the National Vaccination Programme in Finland for risk groups. The number of doses and amounts to be delivered as well as the delivery timetable, are set out in Annex 1 of this Invitation to tender. This procurement is detailed in the Contract Notice published on TED (Tenders Electronic Daily) online version and on the Hilma advertisement website as well as this Invitation to tender and its Annexes as follows.

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 206 260.00 EUR
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
NUTS code: FI
II.2.4)Description of the procurement:

The purpose of STM and the customer is to procure Hepatitis A Vaccine (HAV) required for the National Vaccination Programme in Finland for for adults and children. The number of doses and amounts to be delivered as well as the delivery timetable, are set out in Annex 1 Description of the Procurement. The customer will implement the procurement on STM's side. The roles of STM and customer are described in more detail in Annex 1: Description of the Procurement. The subject of procurement and the mandatory requirements relating to it are described in detail in this invitation to tender and its annexes. Partial tenders will not be considered. Alternative tenders will not be considered. The contract period is 4 years.

II.2.5)Award criteria
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section IV: Procedure

IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2018/S 091-206348
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice

Section V: Award of contract


Contract for Procurement of Hepatitis A Vaccine (HAV)

A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:
V.2.2)Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor
GlaxoSmithKline Oy
NUTS code: FI
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 206 260.00 EUR
V.2.5)Information about subcontracting

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
The Market Court
Radanrakentajantie 5
Telephone: +358 295643300
Fax: +358 295643314

Internet address:

VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice: